Cerenome (PSTV) Interest Coverage Ratio (2011 - 2026)
Plus Therapeutics (PSTV) posted quarterly Interest Coverage Ratio of 418.76 for Q1 2026, down 6389.91% year-over-year from 6.66 in Q1 2025, and down 3637.11% quarter-over-quarter from 11.84 in Q4 2025.
Cerenome (PSTV) Interest Coverage Ratio (2011 - 2026) Analysis & Trends
Plus Therapeutics (PSTV) has reported Interest Coverage Ratio for 16 consecutive years, with 418.76 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Coverage Ratio fell 6389.91% year-over-year to 418.76; the TTM figure through Mar 2026 stood at 83.18 (down 321.12% YoY), while the FY2025 annual figure was 0.59, up 9.3% from the prior year.
- Interest Coverage Ratio slipped to 418.76 in Q1 2026 per PSTV's latest filing, from 11.84 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 11.84 in Q4 2025 and bottomed at 4063.46 in Q3 2025.
- Historically, Interest Coverage Ratio has averaged 313.16 across 5 years, with a median of 32.24 in 2022.
- Annual changes were most pronounced in 2024 — Interest Coverage Ratio tumbled 12425.51% — and 2025, when it soared 144.62%.
- Plus Therapeutics' Interest Coverage Ratio stood at 35.04 in 2022, then jumped by 47.33% to 18.46 in 2023, then slumped by 43.72% to 26.53 in 2024, then soared by 144.62% to 11.84 in 2025, then slumped by 3637.11% to 418.76 in 2026.
- Business Quant data shows PSTV's Interest Coverage Ratio at 418.76 in Q1 2026, 11.84 in Q4 2025, and 4063.46 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Cerenome | 28.07 Mn | 19.48 Mn | - | -1,811.40 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -418.76 |
| Dec 31, 2025 | 11.84 |
| Sep 30, 2025 | -4,063.46 |
| Mar 31, 2025 | -6.45 |
| Dec 31, 2024 | -26.53 |
| Sep 30, 2024 | -59.36 |
| Jun 30, 2024 | -136.93 |
| Mar 31, 2024 | -97.03 |
| Dec 31, 2023 | -18.46 |
| Sep 30, 2023 | -37.37 |
| Jun 30, 2023 | -1.09 |
| Mar 31, 2023 | -47.22 |
| Dec 31, 2022 | -35.04 |
| Sep 30, 2022 | -29.45 |
| Jun 30, 2022 | -25.60 |
| Mar 31, 2022 | -19.63 |
| Dec 31, 2021 | 7.97 |
| Sep 30, 2021 | -17.50 |
| Jun 30, 2021 | -11.24 |
| Mar 31, 2021 | -12.40 |